WASHINGTON ? Federal health officials have expanded approval of an artery-opening stent from Abbott Laboratories to a larger group of patients at risk for stroke caused by plaque in the neck arteries. The Food and Drug Administration said it approved the...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA expands use of Abbott Labs' neck stent
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account